Habitual dietary isoflavone intake is associated with decreased C-reactive protein concentrations among healthy premenopausal women

Journal of Nutrition

Volumn 143, Issue 6, 2013, Pages 900-906

  Filiberto, Amanda C ^a   Mumford, Sunni L ^a   Pollack, Anna Z ^b   Zhang, Cuilin ^a   Yeung, Edwina H ^a   Perkins, Neil J ^a   Wactawski Wende, Jean ^b   Schisterman, Enrique F ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ESTRADIOL; FOLLITROPIN; ISOFLAVONE; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; ARTICLE; BODY MASS; CALORIC INTAKE; CARDIOVASCULAR RISK; DIETARY INTAKE; FEMALE; FIBER; GRAIN; HUMAN; MENSTRUAL CYCLE; PREMENOPAUSE; RACE;

ADOLESCENT; ADULT; ASIAN AMERICANS; BODY MASS INDEX; C-REACTIVE PROTEIN; CEREALS; COHORT STUDIES; DIET; ENERGY INTAKE; ETHNIC GROUPS; FEMALE; FOLLICLE STIMULATING HORMONE; FOOD HABITS; GONADAL STEROID HORMONES; HUMANS; ISOFLAVONES; LUTEINIZING HORMONE; MENSTRUAL CYCLE; PREMENOPAUSE; PROSPECTIVE STUDIES; WOMEN'S HEALTH;

EID: 84878224968     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.112.173187     Document Type: Article

References (37)

1. Setchell KD, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr. 1999;129 Suppl:758S-67S.
2. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-34.
3. Heikkilä K, Harris R, Lowe G, Rumley A, Yarnell J, Gallacher J, Ben-Shlomo Y, Ebrahim S, Lawlor DA. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control. 2009;20:15-26.
4. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98:731-3.
5. Rimbach G, Boesch-Saadatmandi C, Frank J, Fuchs D, Wenzel U, Daniel H, Hall WL, Weinberg PD. Dietary isoflavones in the prevention of cardiovascular disease-a molecular perspective. Food Chem Toxicol. 2008;46:1308-19.
6. D'Anna R, Baviera G, Corrado F, Cancellieri F, Crisafulli A, Squadrito F. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women. Acta Obstet Gynecol Scand. 2005;84:474-7.
7. Greany KA, Nettleton JA, Wangen KE, Thomas W, Kurzer MS. Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women. Eur J Clin Nutr. 2008;62:1419-25.
8. Jenkins DJ, Kendall CW, Connelly PW, Jackson CJ, Parker T, Faulkner D, Vidgen E. Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women. Metabolism. 2002;51:919-24.
9. Nikander E, Metsa-Heikkila M, Tiitinen A, Ylikorkala O. Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women. J Clin Endocrinol Metab. 2003;88:5180-5.
10. Ryan-Borchers TA, Park JS, Chew BP, McGuire MK, Fournier LR, Beerman KA. Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr. 2006;83:1118-25.
11. Gaskins AJ, Wilchesky M, Mumford SL, Whitcomb BW, Browne RW, Wactawski-Wende J, Perkins NJ, Schisterman EF. Endogenous reproductive hormones and C-reactive protein across the menstrual cycle: the BioCycle Study. Am J Epidemiol. 2012;175:423-31.
12. Wactawski-Wende J, Schisterman EF, HoveyKM, Howards PP, BrowneRW, Hediger M, Liu A, Trevisan M; BioCycle Study Group. BioCycle Study: design of the longitudinal study of the oxidative stress and hormone variation during the menstrual cycle. Paediatr Perinat Epidemiol. 2009;23:171-84.
13. Howards PP, Schisterman EF,Wactawski-Wende J, Reschke JE, Frazer AA, Hovey KM. Timing clinic visits to phases of the menstrual cycle by using a fertility monitor: the BioCycle Study. Am J Epidemiol. 2009;169:105-12.
14. USDA, Agricultural Research Service. USDA-Iowa State University database on the isoflavone content of selected foods, release 2.0. Washington: Nutrient Data Laboratory; 2008 [cited 2013 Mar 1]. http://www.ars.usda.gov/nutrientdata.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
17. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381-95.
18. Little RJA, Rubin DB. Statistical analysis with missing data. New York: Wiley & Sons; 1987.
19. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon, RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, et al.; Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511.
20. Littell RC, Henry PR, Ammerman CB. Statistical analysis of repeated measures data using SAS procedures. J Anim Sci. 1998;76:1216-31.
21. Weng HY, Hsueh YH, Messam LL, Hertz-Picciotto I. Methods of covariate selection: directed acyclic graphs and the change-in-estimate procedure. Am J Epidemiol. 2009;169:1182-90.
22. Cole SR, Hernan MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168:656-64.
23. Chun OK, Chung SJ, Song WO. Estimated dietary flavonoid intake and major food sources of U.S. adults. J Nutr. 2007;137:1244-52.
24. Chun OK, Chung SJ, Claycombe KJ, Song WO. Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults. J Nutr. 2008;138:753-60.
25. Dong JY,Wang P, He K, Qin LQ. Effect of soy isoflavones on circulating C-reactive protein in postmenopausal women: meta-analysis of randomized controlled trials. Menopause. 2011;18:1256-62.
26. Maskarinec G, Steude JS, Franke AA, Cooney RV. Inflammatory markers in a 2-year soy intervention among premenopausal women. J Inflamm (Lond). 2009;6:9.
27. Burke-Gaffney A, Hellewell PG. Tumour necrosis factor-alpha-induced ICAM-1 expression in human vascular endothelial and lung epithelial cells: modulation by tyrosine kinase inhibitors. Br J Pharmacol. 1996;119:1149-58.
28. Nagata M, Sedgwick JB, Busse WW. Synergistic activation of eosinophil superoxide anion generation by VCAM-1 and GM-CSF: involvement oftyrosine kinase and protein kinase C. Int Arch Allergy Immunol. 1997;114 Suppl 1:78-80.
29. Weber C. Involvement of tyrosine phosphorylation in endothelial adhesion molecule induction. Immunol Res. 1996;15:30-7.
30. Tanabe J, Watanabe M, Kondoh S, Mue S, Ohuchi K. Possible roles of protein kinases in neutrophil chemotactic factor production by leucocytes in allergic inflammation in rats. Br J Pharmacol. 1994;113:1480-6.
31. Corbett JA, Kwon G, Marino MH, Rodi CP, Sullivan PM, Turk J, McDaniel ML. Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets. Am J Physiol. 1996;270:C1581-7.
32. Siow RC, Li FY, Rowlands DJ, de Winter P, Mann GE. Cardiovascular targets for estrogens and phytoestrogens: transcriptional regulation of nitric oxide synthase and antioxidant defense genes. Free Radic Biol Med. 2007;42:909-25.
33. Jenkins DJ, Kendall CW, Jackson CJ, Connelly PW, Parker T, Faulkner D, Vidgen E, Cunnane SC, Leiter LA, Josse RG. Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr. 2002;76:365-72.
34. Sacks FM, Lichtenstein A, Van HL, Harris W, Kris-Etherton P, Winston M. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation. 2006;113:1034-44.
35. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes: proposed definition and plan for review of dietary antioxidants and related compounds. Washington: National Academies Press; 1998.
36. Chun OK, Chung SJ, Song WO. Urinary isoflavones and their metabolites validate the dietary isoflavone intakes in US adults. J Am Diet Assoc. 2009;109:245-54.
37. Anthony MS, Clarkson TB, Williams JK. Effects of soy isoflavones on atherosclerosis: potential mechanisms. Am J Clin Nutr. 1998;68: 1390S-3S.